Cresp 100mcg Injection(Pfs) 0.5ml

Haematopoiesis Rx required
OUT OF STOCK

Best Price*  ₹ 4,552.00
MRP ₹5,690.00
(Inclusive of all taxes) *This product cannot be returned for a refund or exchange. * Mkt: Dr Reddy'S Laboratories Ltd * Country of Origin: India * Delivery charges if applicable will be applied at checkout



INTRODUCTION

CRESP 100MCG INJECTION(PFS) contains Darbepoetin alfa which belongs to a class of medications called erythropoiesis-stimulating agents (ESAs). It is used to treat anemia. Anemia is a condition where your blood does not contain enough red blood cells and symptoms may be fatigue, weakness and shortness of breath. It works in the same way as erythropoietin, the natural hormone which is produced in your kidneys and encourages your bone marrow to produce more red blood cells.

Always use CRESP 100MCG INJECTION(PFS) as your doctor has told you. It is not recommended for the use in children and adolescents under 18 years. Do not take this medicine, if you have suffered from sickle cell anemia, epileptic fits (seizures) and convulsions (fits or seizures). It should be used with caution in pregnant or breastfeeding women. Consult your doctor before taking this medicine. Tell your doctor, if you are taking or taken or might take any other medicines. The most common side effects include stroke, pain around the area injected, rash and/or redness of the skin, allergic reactions, high blood pressure, blood clots (thrombosis) and fluid retention (oedema).

USES OF CRESP 100MCG INJECTION(PFS)

  • Treat Anemia

HOW CRESP 100MCG INJECTION(PFS) WORKS

It works by causing bone marrow (soft tissue inside the bones where blood is made) to make more red blood cells.

DIRECTIONS FOR USE

Always use CRESP 100MCG INJECTION(PFS) as your doctor has told you. Your injection to be given under the skin (subcutaneous).

SIDE EFFECTS OF CRESP 100MCG INJECTION(PFS)

COMMON

  • stroke
  • pain around the area injected
  • rash and/or redness of the skin
  • allergic reactions
  • high blood pressure
  • blood clots (thrombosis)
  • fluid retention (oedema)

HOW TO MANAGE SIDE EFFECTS

Skin rash:

Avoid bath in hot water because hot water can irritate the skin. Moisturizers can be used regular basis to soothe and hydrate the affected area.

WARNING & PRECAUTIONS

PREGNANCY

CRESP 100MCG INJECTION(PFS) should be used with caution in pregnant women. Consult your doctor before taking this medicine.

BREASTFEEDING

CRESP 100MCG INJECTION(PFS) is not recommended for use in breastfeeding women unless necessary. Discuss the risks and benefits with your doctor.

ALCOHOL

Consumption of alcohol is not recommended during treatment with CRESP 100MCG INJECTION(PFS).

KIDNEY

CRESP 100MCG INJECTION(PFS) should be taken with caution in patients with severe kidney disease. Consult your doctor for advice.

LIVER

CRESP 100MCG INJECTION(PFS) should be taken with caution in patients with severe liver disease. Consult your doctor for advice.

ALLERGY

Do not take if you are allergic to the medicine.

HEART DISEASE

If you have any heart related problems, consult your doctor for advice before taking this medicine.

OTHERS

Do not take this medicine, if you have suffered from sickle cell anemia, epileptic fits (seizures) and convulsions (fits or seizures).

INTERACTIONS

Talk to your doctor if you are using, have recently used or might use any other medicines.

SYNOPSIS

Drug :   Darbepoetin alfa
Pharmacological Category :   Erythropoiesis-stimulating agents
Therapeutic Indication :   Anemia
Dosage Forms :   Injection

MORE INFORMATION

Store in a refrigerator (2-8°C). Do not freeze. Keep out of reach of children.

FAQs ABOUT CRESP 100MCG INJECTION(PFS)

Can CRESP 100MCG INJECTION(PFS) be used in pregnant women?

No. It should be used with caution in pregnant women. Consult your doctor before taking this medicine.

Is CRESP 100MCG INJECTION(PFS) a chemo drug?

It does not treat cancer. It is a support medication in treating anaemia associated with chronic kidney disease (CKD) caused by chemotherapy cancer treatment.

REFERENCES

1. Aleix Cases; Darbepoetin alfa: a novel erythropoiesis-stimulating protein; [Revised on Jul 2003] [Accessed 07 Jan 2021] https://pubmed.ncbi.nlm.nih.gov/12973399/

2. K.D.Tripathi, Essentials of medical pharmacology, DRUGS AFFECTING BLOOD AND BLOOD FORMATION, Chapter 43 – HAEMATINICS AND ERYTHROPOIETIN, 7th edition 2013, Page – 611.

3. Glenmark Pharmaceuticals s.r.o., Amgen; [Revised on Apr 2016] [Accessed 07 Jan 2021] https://www.pi.amgen.com/~/media/amgen/repositorysites/pi-amgen-com/aranesp/ckd/aranesp_pi_hcp_english.pdf

4. Amgen Europe B.V.; Electronic Medicines Compendium (EMC); [Revised on Nov 2019] [Accessed 07 Jan 2021] https://www.medicines.org.uk/emc/files/pil.6958.pdf

PRODUCT DETAILS

    Net Qty
    1
    Ingredient
    DARBEPOETIN ALFA 100MCG
    Hsn Code
    30049099
ALTERNATE BRANDS
DERISE 100mcg Injection(Pfs) 1's
Prescription Haematopoiesis Rx required
Out of stock
Rs.5,200.00
DISCLAIMER

The contents of this website are for informational purposes only and not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of a physician or other qualified health provider with any questions you may have regarding a medical condition. Do not disregard professional medical advice or delay in seeking it because of something you have read on this website.

Copyright© 2021. All Rights Reserved.